2026 PBM Reform: What Plan Sponsors Should Watch
Sequoia frames this issue in a useful way. Sequoia discusses 2026 PBM reform issues employers should watch.
For employers, the value is not the definition. The value is what the definition changes before the company signs another renewal.
Regulatory pressure around PBMs is a signal. Plan sponsors should not wait for Washington to fix their contracts.
Why This Matters To The Business
A law changes later. Your renewal happens sooner. That means your contract still matters now.
That moment shows the real problem. The plan may be expensive, but the bigger issue is often that nobody can explain the machinery underneath it.
For the CEO, this connects to margin, hiring, retention, and risk. Ask whether the company is waiting on reform or using reform pressure as leverage.
For the CFO, this connects to cash flow and control. Ask the PBM what contract terms would change if transparency rules tighten.
The Practical Review
Put the current plan, contract, or renewal proposal on the table. Then ask:
- Who keeps manufacturer rebates?
- Is pricing pass-through, spread, or something dressed up as both?
- Can you audit claims, rebates, and formulary decisions?
Do not accept a vague answer. Do not accept a slide that looks good but leaves the decision unclear. Ask for the document, the number, and the person who owns the next step.
What Good Looks Like
Pharmacy costs are often where opacity hides. Discount language can sound impressive while rebates, spread, formulary choices, and admin fees move money away from the plan.
A transparent PBM conversation should show net cost, who keeps what, what can be audited, and how the contract rewards lower plan spend.
What I would want in the file:
- Rebate flow statement
- Spread or pass-through pricing proof
- Audit rights and formulary review rules
That file does two jobs. It helps leadership make a better decision now. It also creates a record that shows the company acted with care later.
This is the gap I see most often. The employer may have a smart person in HR, a broker presentation, and a spreadsheet. But nobody has a clean decision file. When pressure hits, the company has memories instead of proof.
This topic matters because it changes who has leverage. When the employer understands 2026 pbm reform: what plan sponsors should watch, the conversation moves from a sales pitch to a decision review. That is a different room. It produces different questions.
What To Do Before Renewal
Put PBM reform on the renewal agenda now: rebates, spread, specialty drugs, audit rights, and fiduciary exposure.
This is where proactive strategy beats reactive shopping. Renewal season should not be the first time leadership sees the risk. It should be the point where a prepared team confirms the path.
The Warning Sign
A vendor that says 'nothing to see here' is giving you something to see.
That warning sign is not small. It tells you whether the plan is governed or merely renewed.
Save this line: Use reform pressure as leverage now.
The rules are changing. The exposure is real. The opportunity is massive for employers that move early.
Book 15 minutes at www.Paul.Health if you want this reviewed against your current plan.